Recent Exposure to Four-Factor Prothrombin Complex Concentrate (4F-PCC) is Associated with Intracardiac Thrombus during Liver Transplantation.

被引:0
|
作者
Misel, M. [1 ,2 ]
Schnickel, G. [1 ]
Berumen, J. [1 ]
Sanchez, R. [3 ]
Mekeel, K. [1 ]
机构
[1] UC San Diego Hlth, Div Transplant & Hepatobiliary Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Pharm Inpatient Serv, La Jolla, CA USA
[3] UC San Diego Hlth, Anesthesiol, La Jolla, CA USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
A241
引用
收藏
页码:558 / 558
页数:1
相关论文
共 50 条
  • [21] FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR FACTOR XA INHIBITOR-ASSOCIATED HEMORRHAGE
    Kaplan, Justin
    Procopio, Gabrielle
    Perez, Javier Martin
    Minova, Ljubica
    Bicking, Keri
    Jain, Ruchi
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 259 - 259
  • [22] Tolerability and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) for warfarin and non-warfarin reversals
    Santibanez, M.
    Lesch, C. A.
    Lin, L.
    Berger, K.
    JOURNAL OF CRITICAL CARE, 2018, 48 : 183 - 190
  • [23] The use of four-factor prothrombin complex concentrate in patients with liver disease on warfarin therapy
    Stevens, Craig A.
    Yau, Benny C.
    Lai, Ngan C.
    Huang, Wan-Ting
    Cang, William C.
    Bushway, Audrey
    Derry, Katrina L.
    THROMBOSIS RESEARCH, 2021, 204 : 123 - 125
  • [24] Evaluation of the impact of weight estimations on anticoagulation reversal with 4-factor prothrombin complex concentrate (4F-PCC) in the emergency department
    Vidal, Jennifer
    Procopio, Gabrielle
    Faley, Brian
    PHARMACOTHERAPY, 2016, 36 (12): : E230 - E230
  • [25] Utilization and safety of off-label prothrombin complex concentrate (4F-PCC) in a nonsurgical population
    Sandquist, Katherine
    Kaucher, Kevin
    Newell, Joshua
    Sarangarm, Preeyaporn
    Burnett, Allison
    BLOOD COAGULATION & FIBRINOLYSIS, 2024, 35 (04) : 161 - 166
  • [26] FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN FACTOR XA INHIBITOR-ASSOCIATED INTRACRANIAL BLEEDING
    Korobey, Matthew
    Sadaka, Farid
    Javed, Muhammad Ali
    Moynihan, Meghin
    Alsaei, Ahmed
    CRITICAL CARE MEDICINE, 2020, 48
  • [27] Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single-center, retrospective, matched cohort analysis
    Parsels, Katie A.
    Seabury, Robert W.
    Zyck, Stephanie
    Miller, Christopher D.
    Krishnamurthy, Satish
    Darko, William
    Probst, Luke A.
    Latorre, Julius Gene
    Cwikla, Gregory M.
    Feldman, Elizabeth A.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 55 : 16 - 19
  • [28] USE OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR COAGULOPATHIC BLEEDING DURING CARDIAC SURGERY
    Maynard, Kaylee
    Falvey, Jennifer
    Groth, Christine
    CRITICAL CARE MEDICINE, 2020, 48
  • [29] Case Series of Four-Factor Prothrombin Complex Concentrate for Warfarin Reversal Before Heart Transplantation
    Nuckles, K. B.
    Pratt, J. H.
    Cameron, C. M.
    Ingemi, A. I.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (03) : 841 - 843
  • [30] REDUCED TIME TO GASTROINTESTINAL PROCEDURE AFTER WARFARIN REVERSAL WITH FOUR FACTOR PROTHROMBIN COMPLEX CONCENTRATE (4F-PCC) AS COMPARED TO PLASMA IN PATIENTS WITH GASTROINTESTINAL BLEEDING
    McRae, Hannah L.
    Spector, Hannah
    Love, Tanzy
    Sturpe, Deborah
    Northam, Kalynn
    Refaai, Majed A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E72 - E72